Ligand Pharmaceuticals Incorporated · NASDAQ:LGND

BlackRock, Inc. reported a 14.50% stake in Ligand Pharmaceuticals Incorporated (Schedule 13G/A)

Event Sep 30, 2025 · Filed Oct 17, 2025

BlackRock, Inc. reported a 14.50% stake in Ligand Pharmaceuticals Incorporated, 2,839,251 shares, as a passive investor on Sep 30, 2025. Filed Oct 17, 2025 (Schedule 13G/A).

Stake
14.50%
Shares
2,839,251
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
BlackRock, Inc.14.50%2,839,251

Source

View original at SEC

Related